Acta Biomedica Scientifica (May 2012)

STUDYING OF APPLICATION IMMUNOMODULATOR «GALAVIT» AT EXPERIMENTAL ATHEROSCLEROSIS

  • E. P. Turmova,
  • A. A. Grigoryuk,
  • E. A. Bichkov,
  • E. V. Markelova,
  • I. V. Chihkalovets

Journal volume & issue
Vol. 0, no. 3(2)
pp. 323 – 326

Abstract

Read online

The changes of the cytokines and lipidic spectrum at experimental hyperlipoidemia and arterial hypertensia was made at 20 rats «Vistar» during 6 months. As the material of research was the blood serum. The cytokines was made by the method solid-phase not competitive immune-enzyme analysis with the use of sets: Rat «R&D Diagnostics Inc.», USA. The content of the general cholesterol; triglycerides; LDL; HDL was investigated by the method of standard colorimetric analysis with the use of reagents «Olveks diagnosticum» (Russia). The increasing of the general cholesterol, LDL; HDL, atherogenic coefficient, IFN-γ and IL-1β in blood of animals was revealed. At application of immunomodulator «Galavit» at experimental atherosclerosis the decreasing contains of IL-1, IFN-γ, the level of general cholesterol; LDL; HDL, atherogenic coefficient is fixed.

Keywords